Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:09:43 UTC |
---|
Update Date | 2021-09-14 15:48:01 UTC |
---|
HMDB ID | HMDB0060962 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 3-hydroxyropivacaine |
---|
Description | 3-hydroxyropivacaine belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. 3-hydroxyropivacaine is a very strong basic compound (based on its pKa). The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. Ropivacaine is a local anaesthetic drug belonging to the amino amide group. 3-hydroxyropivacaine is a metabolite of ropivacaine. |
---|
Structure | CCCN1CCCC[C@@H]1C(O)=NC1=C(C)C=CC(O)=C1C InChI=1S/C17H26N2O2/c1-4-10-19-11-6-5-7-14(19)17(21)18-16-12(2)8-9-15(20)13(16)3/h8-9,14,20H,4-7,10-11H2,1-3H3,(H,18,21)/t14-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C17H26N2O2 |
---|
Average Molecular Weight | 290.4005 |
---|
Monoisotopic Molecular Weight | 290.199428086 |
---|
IUPAC Name | (2R)-N-(3-hydroxy-2,6-dimethylphenyl)-1-propylpiperidine-2-carboximidic acid |
---|
Traditional Name | (2R)-N-(3-hydroxy-2,6-dimethylphenyl)-1-propylpiperidine-2-carboximidic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCN1CCCC[C@@H]1C(O)=NC1=C(C)C=CC(O)=C1C |
---|
InChI Identifier | InChI=1S/C17H26N2O2/c1-4-10-19-11-6-5-7-14(19)17(21)18-16-12(2)8-9-15(20)13(16)3/h8-9,14,20H,4-7,10-11H2,1-3H3,(H,18,21)/t14-/m1/s1 |
---|
InChI Key | IXOVDWXTIIYVOJ-CQSZACIVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- 2-piperidinecarboxamide
- Piperidinecarboxamide
- Anilide
- Xylenol
- M-xylene
- Xylene
- P-cresol
- N-arylamide
- O-cresol
- Phenol
- 1-hydroxy-2-unsubstituted benzenoid
- Piperidine
- Benzenoid
- Monocyclic benzene moiety
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Carboxamide group
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-hydroxyropivacaine,1TMS,isomer #1 | CCCN1CCCC[C@@H]1C(=NC1=C(C)C=CC(O)=C1C)O[Si](C)(C)C | 2235.1 | Semi standard non polar | 33892256 | 3-hydroxyropivacaine,1TMS,isomer #2 | CCCN1CCCC[C@@H]1C(O)=NC1=C(C)C=CC(O[Si](C)(C)C)=C1C | 2266.9 | Semi standard non polar | 33892256 | 3-hydroxyropivacaine,2TMS,isomer #1 | CCCN1CCCC[C@@H]1C(=NC1=C(C)C=CC(O[Si](C)(C)C)=C1C)O[Si](C)(C)C | 2298.5 | Semi standard non polar | 33892256 | 3-hydroxyropivacaine,1TBDMS,isomer #1 | CCCN1CCCC[C@@H]1C(=NC1=C(C)C=CC(O)=C1C)O[Si](C)(C)C(C)(C)C | 2424.5 | Semi standard non polar | 33892256 | 3-hydroxyropivacaine,1TBDMS,isomer #2 | CCCN1CCCC[C@@H]1C(O)=NC1=C(C)C=CC(O[Si](C)(C)C(C)(C)C)=C1C | 2471.7 | Semi standard non polar | 33892256 | 3-hydroxyropivacaine,2TBDMS,isomer #1 | CCCN1CCCC[C@@H]1C(=NC1=C(C)C=CC(O[Si](C)(C)C(C)(C)C)=C1C)O[Si](C)(C)C(C)(C)C | 2690.1 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3-hydroxyropivacaine GC-MS (Non-derivatized) - 70eV, Positive | splash10-000b-9810000000-7acf0f53478a7519055e | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-hydroxyropivacaine GC-MS (2 TMS) - 70eV, Positive | splash10-05bb-9331300000-19c714aa941ae4a57167 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-hydroxyropivacaine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 10V, Positive-QTOF | splash10-000f-0970000000-54ae3bdef9ba245c7389 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 20V, Positive-QTOF | splash10-004r-2900000000-87e117fede1bb2be7a8a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 40V, Positive-QTOF | splash10-000x-9300000000-8dc96f8f7acca723ad63 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 10V, Negative-QTOF | splash10-000i-0190000000-44e36d2dfbc547648366 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 20V, Negative-QTOF | splash10-000i-0960000000-1fd4fefe9f449f37afa6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 40V, Negative-QTOF | splash10-0a5i-7900000000-bee7afe3c30b774e2ba6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 10V, Positive-QTOF | splash10-0006-0490000000-2116bdfdf05c5f6e7f79 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 20V, Positive-QTOF | splash10-004i-1920000000-51d5b249484b24038424 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 40V, Positive-QTOF | splash10-004j-4900000000-1eaa9f83312df113715e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 10V, Negative-QTOF | splash10-000i-0090000000-3f77951545ee2559c16a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 20V, Negative-QTOF | splash10-000i-1890000000-06bd65d148e83e1e45ce | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-hydroxyropivacaine 40V, Negative-QTOF | splash10-001i-2920000000-d609ce666238ccb26169 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|